×
Annexon Net Profit Margin 2019-2025 | ANNX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Annexon net profit margin from 2019 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Annexon Net Profit Margin 2019-2025 | ANNX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Annexon net profit margin from 2019 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$228.5B
Amgen (AMGN)
$165.9B
Gilead Sciences (GILD)
$140.8B
Vertex Pharmaceuticals (VRTX)
$121.3B
Bristol Myers Squibb (BMY)
$99.6B
CSL (CSLLY)
$86.2B
GSK (GSK)
$78.3B
Regeneron Pharmaceuticals (REGN)
$61B
Alnylam Pharmaceuticals (ALNY)
$42.8B
Argenex SE (ARGX)
$36.2B
BioNTech SE (BNTX)
$27.5B
Royalty Pharma (RPRX)
$20.6B
Insmed (INSM)
$19.6B
Biogen (BIIB)
$19.4B
Illumina (ILMN)
$17B
Genmab (GMAB)
$15.2B
Genmab (GNMSF)
$14.9B
Incyte (INCY)
$13.6B
Moderna (MRNA)
$13.2B
Exelixis (EXEL)
$12.2B
BioMarin Pharmaceutical (BMRN)
$11.5B
QIAGEN (QGEN)
$11.4B
Swedish Orphan Biovitrum (BIOVF)
$10.6B
Ascendis Pharma (ASND)
$10.3B
Exact Sciences (EXAS)
$9.2B
Bio-Techne Corp (TECH)
$9.2B
Verona Pharma American Depositary Share (VRNA)
$8.9B
Blueprint Medicines (BPMC)
$8.3B
Legend Biotech (LEGN)
$8.1B
Roivant Sciences (ROIV)
$7.7B